COMBINATION THERAPY FOR REDUCING THE RISKS ASSOCIATED WITH CARDIOVASCULAR DISEASE

The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet agg...

Full description

Saved in:
Bibliographic Details
Main Authors OLOFSSON, LARS, RHYMER, PATRICIA, A, NICHTBERGER, STEVEN, A, GOULD, ROBERT, J
Format Patent
LanguageEnglish
French
German
Published 07.05.2003
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet aggregation, for inhibiting the formation of thrombotic occlusions, and for treating, preventing and reducing the risk of occurrence of cardiovascular and cerebrovascular events and related vaso-occlusive disorders.
AbstractList The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet aggregation, for inhibiting the formation of thrombotic occlusions, and for treating, preventing and reducing the risk of occurrence of cardiovascular and cerebrovascular events and related vaso-occlusive disorders.
Author RHYMER, PATRICIA, A
GOULD, ROBERT, J
NICHTBERGER, STEVEN, A
OLOFSSON, LARS
Author_xml – fullname: OLOFSSON, LARS
– fullname: RHYMER, PATRICIA, A
– fullname: NICHTBERGER, STEVEN, A
– fullname: GOULD, ROBERT, J
BookMark eNqNyksKwjAQgOEsdOHrDnMBQbH4WI7J1AxqUzOp4qoUiStJC_X-iOABXP3w8Y_VILUpjtRFu_OeCwzsCgiWPJZ3yJ0HT6bSXBy-CJ7lKIAiTjMGMnDjYEGjN-yuKLo6oQfDQig0VcNn8-rj7NeJgpyCtvPYtXXsu-YRU3zXVC522Xq52WK2-mP5AIvxMOw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate TRAITEMENT COMBINE DESTINE A REDUIRE LES RISQUES DE MALADIES CARDIO-VASCULAIRES
KOMBINATIONSTHERAPIE ZUR VERMINDERUNG DER MIT HERZ-KREISLAUFERKRANKUNGEN EINHERGERGENDEN RISIKEN
Edition 6
ExternalDocumentID EP0946178A4
GroupedDBID EVB
ID FETCH-epo_espacenet_EP0946178A43
IEDL.DBID EVB
IngestDate Fri Jul 19 16:04:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP0946178A43
Notes Application Number: EP19970941644
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030507&DB=EPODOC&CC=EP&NR=0946178A4
ParticipantIDs epo_espacenet_EP0946178A4
PublicationCentury 2000
PublicationDate 20030507
PublicationDateYYYYMMDD 2003-05-07
PublicationDate_xml – month: 05
  year: 2003
  text: 20030507
  day: 07
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies MERCK & CO., INC
RelatedCompanies_xml – name: MERCK & CO., INC
Score 2.56986
Snippet The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMBINATION THERAPY FOR REDUCING THE RISKS ASSOCIATED WITH CARDIOVASCULAR DISEASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030507&DB=EPODOC&locale=&CC=EP&NR=0946178A4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFH5BNOpNUSP-Sg9mt8WJcxsHYko3XFXY3AbqiWxjTbgMIjP--75WQC96a9qkaZt-7_Vr3_cKcIkso2VMrh1dFFKSYxVt3XEyUxciLYzcbNtGKtXI_YHlD82H19vXGkxXWhiVJ_RTJUdEROWI90rZ6_nPJZarYisXV9kUq2Z3vaTjait2jLvXsDW32_HCwA2YxhiWtEHUQRYjxXDU3IBNPEXbirONulKUMv_tUXp7sBViZ2W1D7WibMAOW3281oDt_vK9G4tL6C0O4JkF_S7_Tl5LEt-LaPhGkMKRSH6ewwf3spJEPH6MicrVyCkaJfLCE58wGrk8GNGYDZ9oRFweezT2DoH0vIT5Oo5tvF6HsReuZ3FzBPVyVhbHQISYiFzk2cQyUgnINBUtIczUdBCvVstsQvPPbk7-aTuFXRW4JoP77DOoV-8fxTk64Cq7UEv3BfNihEw
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFH5BNOJNUSP-7MHstjhxjnEgZnTDVdiG20A8kW2sCZdBZMZ_39cq6EVvTZs0bdPvvX7t-14BrpFlNLXZranyXEhyjLytmmaqq5wnuZbp7ZaWCDWy5xvuSH-a3E8qMF9rYWSe0A-ZHBERlSHeS2mvlz-XWLaMrVzdpHOsWjz04o6trNkx7l6tpdjdjjMM7IAqlGJJ8cMOshghhrP0LdjGE7YpmdK4K0Qpy98epbcPO0PsrCgPoJIXdajR9cdrddj1vt-7sfgNvdUhPNPA67Kv5LUkdp3QGr4SpHAkFJ_nMP9RVJKQRf2IyFyNzEKjRF5Y7BJqhTYLxlZERwMrJDaLHCtyjoD0nJi6Ko5tulmHqTPczOLuGKrFoshPgHA-4xnP0pmhJQKQScKbnOuJbiJejabegMaf3Zz-03YFNTf2BtMB8_tnsCeD2ESgX-scquXbe36BzrhML-UyfgJQB4c8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATION+THERAPY+FOR+REDUCING+THE+RISKS+ASSOCIATED+WITH+CARDIOVASCULAR+DISEASE&rft.inventor=OLOFSSON%2C+LARS&rft.inventor=RHYMER%2C+PATRICIA%2C+A&rft.inventor=NICHTBERGER%2C+STEVEN%2C+A&rft.inventor=GOULD%2C+ROBERT%2C+J&rft.date=2003-05-07&rft.externalDBID=A4&rft.externalDocID=EP0946178A4